Explore the latest news and publications, innovation milestones, and drug-device insights from PARI and our pharmaceutical partners leveraging eFlow® Technology.
Recent announcements, achievements, and development milestones from PARI's pharmaceutical partners utilizing eFlow® Technology.
Insmed Presents Broad Range of Data Across Its Three Programs at the American Thoracic Society 2021 International Conference
Key data on economic impact of Bronchiolitis Obliterans Syndrome (BOS) presented at ISHLT 2021
LAMIRA®, an eFlow® Technology nebulizer, expected to launch in Japan as a medical device for exclusive administration of ARIKAYCE® (amikacin liposome inhalation suspension)
Santhera Announces Positive Results with Lonodelestat in Early Phase Cystic Fibrosis Trial
Insmed Initiates Frontline Clinical Trial Program for ARIKAYCE® (amikacin liposome inhalation suspension) in Patients with MAC Lung Disease